Moderna Inc

Pfizer RSV vaccine protects older adults over two seasons

Read more

Moderna (MRNA) earnings Q4 2023

Read more

GSK posts blowout RSV vaccine sales, raises outlook

Read more

Big pharma Merck, Bristol Myers, J&J prepare to lose revenue

Read more

Merck, J&J CEOs agree to testify in Senate hearing on drug prices

Read more

Moderna Covid vaccine sales plunge in 2023, but meet company forecast

Read more

Moderna stock jumps after Oppenheimer upgrade on pipeline potential

Read more

Health sector themes to watch in 2024

Read more

Moderna, Merck cancer vaccine reduces risk of skin cancer return

Read more

Pfizer 2024 revenue, profit forecast disappoints

Read more